ClinConnect ClinConnect Logo
Search / Trial NCT06650085

Protective Ileostomy Versus Protective Colostomy in Anterior Rectal Resection

Launched by HELSINKI UNIVERSITY CENTRAL HOSPITAL · Oct 18, 2024

Trial Information

Current as of June 26, 2025

Not yet recruiting

Keywords

ClinConnect Summary

This clinical trial is comparing two types of temporary surgical openings called stomas: loop ileostomy and loop colostomy. Both of these procedures can be used to help protect the intestines after a surgery called anterior rectal resection, which is done to remove part of the rectum due to cancer. The goal of the trial is to find out which type of stoma has fewer problems or complications in the first 60 days after surgery.

To participate in this trial, patients need to be between the ages of 18 and 74 and scheduled for anterior rectal resection with the plan to create a protective stoma. However, those who already have a stoma, have certain anatomical issues, or cannot cooperate due to other medical reasons will not be eligible. If you join the trial, you will be randomly assigned to receive either a loop ileostomy or a loop colostomy during your surgery. The research aims to provide more information on the best option for patients undergoing this type of surgery.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria: Patients undergoing anterior resection (resection of the rectum and colorectal or coloanal anastomosis) due to a rectal tumour and a protective stoma is planned.
  • The exclusion criteria are: (1) patient already having a stoma (or another stoma made during surgery), (2) technical inability to create ileo- or colostomy (e.g. previous bowel resection, anatomical factors), (3) age \<18 years, (4) inadequate ability to co-operate.

About Helsinki University Central Hospital

Helsinki University Central Hospital (HUCH) is a leading academic medical institution in Finland, dedicated to advancing healthcare through innovative research and clinical excellence. As a pivotal sponsor of clinical trials, HUCH integrates cutting-edge medical practices with rigorous scientific inquiry, fostering collaborations between researchers, healthcare professionals, and patients. The hospital is committed to enhancing patient outcomes and contributing to the global body of medical knowledge by conducting high-quality, ethically sound clinical studies across a diverse range of therapeutic areas. With a strong emphasis on education and training, HUCH plays a vital role in shaping the next generation of healthcare leaders and researchers.

Locations

Helsinki, , Finland

Tampere, , Finland

Turku, , Finland

Patients applied

0 patients applied

Trial Officials

Ville Sallinen, MD, PhD

Principal Investigator

Helsinki University Central Hospital

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported